Antihypertensive peptides from natural resources

Advances in Phytomedicine

Volumn 2, Issue C, 2006, Pages 255-271

  Matsui, Toshiro ^a   Matsumoto, Kiyoshi ^a  

^a NONE

Author keywords

angiotensin I converting enzyme; functional food; hypertension; peptide

Indexed keywords

EID: 77957028497     PISSN: 1572557X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1572-557X(05)02015-5     Document Type: Review

References (40)

1. Adibi S.A., and Morse E.L. Intestinal transport of dipeptides in man. J Clin Invest 50 (1971) 2266-2275
2. Amarowicz R., and Shahidi F. Antioxidant activity of peptide fractions of capelin protein hydrolysates. Food Chem 58 (1997) 355-359
3. Cheung H.-S., Wang F.-L., Ondetti M.A., Sabo E.F., and Cushman D.W. Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. J Biol Chem 255 (1980) 401-407
4. Ehler M.R.W., and Riordan J.F. In: Laraph J.H., and Brenner B.M. (Eds). Hypertension: pathophysiology, diagnosis, and management (1990), Raven Press, New York 1217
5. Gardner M.L.G. Absorption of intact peptides: studies on transport of protein digests and dipeptides across rat small intestine in vitro. Quarterly J Exp Physiol 67 (1982) 629-637
6. Hartleb M., and Leuschner J. Toxicological profile of a low molecular weight spleen peptide formulation used in supportive cancer therapy. Drug Res 47 (1997) 1047-1051
7. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., and Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64 (1996) 767-771
8. Isono Y. Peptide inhibitors for angiotensin I-converting enzyme from Masai fermented milk. Food Sci Technol Int 2 (1996) 213-216
9. Johnston C.I., and Burrell L.M. Evolution of blockade of the renin-angiotensin system. J Human Hypertens 9 (1995) 375-380
10. Kato H., Rhue M.R., and Nishimura T. In: Teranishi R., Buttery R.G., and Shahidi F. (Eds). Flavor chemistry - trends and developments (1989), ACS Symposium Series 388, Washington, DC 158
11. Kawamura Y. Prospects and basic problems of physiologically active peptides derived from food proteins. Shokuhin to Kaihatsu (in Japanese) 26 (1990) 28-32
12. Kawasaki T., Seki E., Osajima K., Yoshida M., Asada K., Matsui T., and Osajima Y. Antihypertensive effect of Valyl-Tyrosine, a short chain peptide derived from sardine muscle hydrolysate. J Human Hypertens 14 (2000) 519-523
13. Kinoshita E., Yamakoshi J., and Kikuchi M. Purification and identification of an angiotensin I-converting enzyme inhibitor from soy source. Biosci Biotechnol Biochem 57 (1993) 1107-1110
14. Kohama Y., Matsumoto S., Oka H., Teramoto T., Okabe M., and Mimura T. Isolation of angiotensin converting enzyme inhibitor from tuna muscle. Biochem Biophys Res Commun 155 (1988) 332-337
15. Li C.-H., Matsui T., and Osajima Y. Latent production of angiotensin I-converting enzyme inhibitors from buckwheat protein. J Peptide Sci 8 (2002) 267-274
16. Maruyama S., and Suzuki H. A peptide inhibitor of angiotensin I converting enzyme in the tryptic hydrolysate of casein. Agric Biol Chem 46 (1982) 1393-1394
17. Matsufuji H., Matsui T., Ohshige S., Kawasaki T., Osajima K., and Osajima Y. Antihypertensive effects of angiotensin fragments in SHR. Biosci Biotechnol Biochem 59 (1995) 1398-1401
18. Matsui T., Li C.-H., and Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. J Peptide Sci 5 (1999) 289-297
19. Matsui T., Matsufuji H., Seki E., Osajima K., Nakashima M., and Osajima Y. Inhibition of angiotensin I-converting enzyme by Bacillus licheniformis alkaline protease hydrolysates derived from sardine muscle. Biosci Biotechnol Biochem 57 (1993) 922-925
20. Matsui T., Tamaya K., Kawasaki T., and Osajima Y. Determination of angiotensin metabolites in human plasma by fluorimetric high-performance liquid chromatography using a heart-cut column-switching technique. J Chromatogr B 729 (1999) 89-95
21. Matsui T., Li C.-H., Tanaka T., Maki T., Osajima Y., and Matsumoto K. Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rats and human plasma. Biol Pharm Bull 23 (2000) 427-431
22. Matsui T., Tamaya K., Seki E., Osajima K., Matsumoto K., and Kawasaki T. Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system. Clin Exp Pharm Physiol 29 (2002) 204-208
23. Matsui T., Tamaya K., Seki E., Osajima K., Matsumoto K., and Kawasaki T. Absorption of Val-Tyr with in vitro angiotensin I-converting enzyme inhibitory activity into the circulating blood system of mild hypertensive subjects. Biol Pharm Bull 25 (2002) 1228-1230
24. Matsui T., Yukiyoshi A., Doi S., Sugimoto H., Yamada H., and Matsumoto K. Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J Nutr Biochem 13 (2002) 80-86
25. Matsui T., Hayashi A., Tamaya K., Matsumoto K., Kawasaki T., Murakami K., and Kimoto K. Depressor effect induced by dipeptide, Val-Tyr, in hypertensive transgenic mice is, in part, due to the suppression of human circulating renin-angiotensin system. Clin Exp Pharm Physiol 30 (2003) 262-265
26. Matsumura N., Fujii M., Takeda Y., Sugita K., and Shimizu T. Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotechnol Biochem 57 (1993) 695-697
27. Mullally M.M., Meisel H., and FitzGerald R.J. Identification of a novel angiotensin I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Lett 402 (1997) 99-101
28. Natoff I.L. Preclinical studies on angiotensin converting enzyme inhibitors. Cardiovasc Drugs and Therapy 1 (1987) 15-27
29. Okunishi T., Kawamoto Y., Kurobe Y., Oka K., Ishii K., Tanaka M., and Miyazaki M. Pathogenic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat. Clin Exp Pharm Physiol 18 (1991) 649-659
30. Saito Y., Wanezaki K., Kawano A., and Imayasu S. Antihypertensive effects of peptide in Sake and its by-products on spontaneously hypertensive rats. Biosci Biotechnol Biochem 58 (1994) 812-816
31. Sealey J.E., and Laragh J.H. In: Laraph J.H., and Brenner B.M. (Eds). Hypertension: pathophysiology, diagnosis, and management (1990), Raven Press, New York 1287
32. Seki E., Osajima K., Matsufuji H., Matsui T., and Osajima Y. Val-Tyr, an angiotensin I-converting enzyme inhibitor from sardines that have resistance to gastrointestinal proteases. Nippon Nogeikagaku Kaishi (in Japanese) 69 (1995) 1013-1020
33. Seki E., Osajima K., Matsufuji H., Matsui T., and Osajima Y. Immunological applicability for foods of short chain peptides derived from sardines. Nippon Nogeikagaku Kaishi (in Japanese) 69 (1995) 1171-1174
34. Seki E., Kawasaki T., Yoshida M., Osajima K., Tamaya K., Matsui T., and Osajima Y. Antihypertensive effect of sardine peptide and Val-Tyr in SHR. Nippon Eiyo Shokuryo Gakkaishi (in Japanese) 52 (1999) 271
35. Sekiya S., Kobayashi Y., Kita E., Imamura Y., and Toyama S. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J Jpn Soc Nutr Food Sci 45 (1992) 513-517
36. Silk D.B.A., Fairclough P.D., Clark M.L., Hegarty J.E., Marrs T.C., Addison J.M., Burston D., Clegg K.M., and Matthews D.M. Use of a peptide rather than free amino acid nitrogen source in chemically defined elemental diets. J Parenter Enteral Nutr 4 (1980) 548-553
37. Sugiyama K., Takada K., Egawa M., Yamamoto I., Onzuka H., and Oba K. Hypotensive effect of fish protein hydrolysate. Nippon Nogeikagaku Kaishi (in Japanese) 65 (1991) 35-43
38. Tsuchihata H., Suzuki T., and Kuwata T. The effect of casein phosphopeptides on calcium absorption from calcium-fortified milk in growing rats. Br J Nutr 85 (2001) 5-10
39. Ukeda H., Matsuda H., Kuroda H., Osajima K., Matsufuji H., and Osajima Y. Preparation and separation of angiotensin I-converting enzyme inhibitory peptides. Nippon Nogeikagaku Kaishi (in Japanese) 65 (1991) 1223-1228
40. Yang C.Y., Dantzig A.H., and Pidgeon C. Intestinal peptide transport systems and oral drug availability. Pharm Res 16 (1999) 1331-1343